Endocrine dysfunction in patients with Fabry disease

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 11, 2006, Pages 4319-4325

  Faggiano, Antongiulio ^a   Pisani, A ^a   Milone, F ^a   Gaccione, M ^a   Filippella, M ^a   Santoro, A ^a   Vallone, G ^a   Tortora, F ^a   Sabbatini, M ^a   Spinelli, L ^a   Lombardi, G ^a   Cianciaruso, B ^a   Colao, A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; CORTICOTROPIN; GLOBOTRIAOSYLCERAMIDE; GROWTH HORMONE; SOMATOMEDIN C; THYROID ANTIBODY;

ADRENAL GLAND; ADULT; ARTICLE; ASTHENOSPERMIA; BODY WEIGHT; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; ENDOCRINE DISEASE; ENDOCRINE GLAND; ENZYME REPLACEMENT; FABRY DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; GONAD; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPOTHYROIDISM; MALE; MENSTRUATION DISORDER; OLIGOSPERMIA; PRIORITY JOURNAL; SEMINAL PLASMA; SPONTANEOUS ABORTION; THYROID GLAND; VASCULARIZATION;

EID: 33751512520     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0858     Document Type: Article

References (40)

1. Fabry H 2002 Angiokeratoma corporis diffusum-Fabry disease: historical review from the original description to the introduction of enzyme replacement therapy. Acta Paediatr Suppl 91:3-5
2. Linhart A, Magage S, Palecek T, Bultas J 2002 Cardiac involvement in Fabry disease. Acta Paediatr Suppl 91:15-20
3. Meroni M, Sessa A, Battini G, Tazzari S, Torri Tarelli L 1997 Kidney involvement in Anderson-Fabry disease. Contrib Nephrol 122:178-184
4. Crutchfield KE, Patronas NJ, Dambrosia JM, Frei KP, Banerjee TK, Barton NW, Schiffmann R 1998 Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology 50:1746-1749
5. Mendez MF, Stanley TM, Medel NM, Li Z, Tedesco DT 1997 The vascular dementia of Fabry's disease. Dement Geriatr Cogn Disord 8:252-257
6. Argoff CE, Barton NW, Brady RO, Ziessman HA 1998 Gastrointestinal symptoms and delayed gastric emptying in Fabry's disease: response to metoclopramide. Nucl Med Commun 19:887-891
7. MacDermot KD, Holmes A, Miners AH 2001 Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 38:750-760
8. MacDermot KD, Holmes A, Miners AH 2001 Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38:769-775
9. MacDermot KD, Holmes A, Miners AH 2001 Natural history of Fabry disease in affected males and obligate carrier females. J Inherit Metab Dis 24(Suppl 2):13-14; discussion 11-12
10. Feldt-Rasmussen U, Rasmussen AK, Mersebach H, Rosenberg KM, Hasholt L, Sorensen SA 2002 Fabry disease: a metabolic disorder with a challenge for endocrinologists? Horm Res 58:259-265
11. Nistal M, Paniagua R, Picazo ML 1983 Testicular and epididymal involvement in Fabry's disease. J Pathol 141:113-124
12. Tojo K, Oota M, Honda H, Shibasaki T, Sakai O 1994 Possible thyroidal involvement in a case of Fabry disease. Intern Med 33:172-176
13. Desnick RJ, Allen KY, Simmons RL, Woods JE, Anderson CF, Najarian JS, Krivit W 1973 Fabry disease: correction of the enzymatic deficiency by renal transplantation. Birth Defects Orig Artic Ser 9:88-96
14. National Kidney Foundation 2002 Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1-S266
15. Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F, Ghigo E 1998 Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 83:1615-1618
16. Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C, Lombardi G, Colao A 2003 Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 88:2527-2533
17. Ware Jr JE, Kemp JP, Buchner DA, Singer AE, Nolop KB, Goss TF 1998 The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults. Qual Life Res 7:235-244
18. World Health Organization 1999 WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4th ed. Cambridge, UK: Cambridge University Press
19. Dumont JE, Lamy F, Roger P, Maenhaut C 1992 Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 72:667-697
20. Spinelli L, Pisani A, Sabbatini M, Petretta M, Andreucci MV, Procaccini D, Lo Surdo N, Federico S, Cianciaruso B 2004 Enzyme replacement therapy with agalsidase β improves cardiac involvement in Fabry's disease. Clin Genet 66:158-165
21. Pisani A, Spinelli L, Sabbatini M, Andreucci MV, Procaccini D, Abbaterusso C, Pasquali S, Savoldi S, Comotti C, Cianciaruso B 2005 Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement. Am J Kidney Dis 46:120-127
22. Guffon N, Fouilhoux A 2004 Clinical benefit in Fabry patients given enzyme replacement therapy: a case series. J Inherit Metab Dis 27:221-227
23. Roberts CG, Ladenson PW 2004 Hypothyroidism. Lancet 363:793-803
24. Marzotti S, Falorni A 2004 Addison's disease. Autoimmunity 37:333-336
25. Guin GH, Burns WA, Saini N, Jones WP 1976 Diffuse angiokeratoma (Fabry's disease): case report. Mil Med 141:259-263
26. Hauser AC, Gessl A, Lorenz M, Voigtlander T, Fodinger M, Sunder-Plassmann G 2005 High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease. J Inherit Metab Dis 28:715-722
27. Demers LM, Spencer CA 2003 Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol (Oxf) 58:138-140
28. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR; Guidelines Committee, National Academy of Clinical Biochemistry 2003 Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3-126
29. Pedersen OM, Aardal NP, Larssen TB, Varhaug JE, Myking O, Vik-Mo H 2000 The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid 10:251-259
30. Hauser AC, Gessl A, Harm F, Wiesholzer M, Kleinert J, Wallner M, Voigtlander T, Bieglmayer C, Sunder-Plassmann G 2005 Hormonal profile and fertility in patients with Anderson-Fabry disease. Int J Clin Pract 59:1025-1028
31. LeRoith D, Danovitz G, Trestian S, Spitz IM 1980 Dissociation of pituitary glycoprotein response to releasing hormones in chronic renal failure. Acta Endocrinol (Copenh) 93:277-282
32. Sievertsen GD, Lim VS, Nakawatase C, Frohman LA 1980 Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure. J Clin Endocrinol Metab 50:846-852
33. Altarescu G, Moore DF, Pursley R, Campia U, Goldstein S, Bryant M, Panza JA, Schiffmann R 2001 Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke 32:1559-1562
34. Brady RO, Schiffmann R 2000 Clinical features of and recent advances in therapy for Fabry disease. JAMA 284:2771-2775
35. Chakraborty J, Hikim AP, Jhunjhunwala JS 1985 Stagnation of blood in the microcirculatory vessels in the testes of men with varicocele. J Androl 6:117-126
36. Ottander U, Solensten NG, Bergh A, Olofsson JI 2004 Intraovarian blood flow measured with color Doppler ultrasonography inversely correlates with vascular density in the human corpus luteum of the menstrual cycle. Fertil Steril 81:154-159
37. Ying SY 1988 Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 9:267-293
38. Oelkers W 1996 Adrenal insufficiency. N Engl J Med 335:1206-1212
39. Perlitz Y, Varkel J, Markovitz J, Ben Ami M, Matilsky M, Oettinger M 1999 Acute adrenal insufficiency during pregnancy and puerperium: case report and literature review. Obstet Gynecol Surv 54:717-722
40. Allan WC, Haddow JE, Palomaki GE, Williams JR, Mitchell ML, Hermos RJ, Faix JD, Klein RZ 2000 Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 7:127-130